{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:16Z","timestamp":1789706236559,"version":"4.0.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"name":"Argentinean National Scientific and Technological Promotion Agency","award":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"],"award-info":[{"award-number":["PIP-CONICET 0183, PIP-CONICET 11220200102951, PICT-2021-CAT-I00166, PICT-2020-SERIEA-02706 and PICT-2020-SERIEA-02255 Rai\u0301ces (III), PICT 2018-2989, PICT 2018-3379, PICT2019-04417"]}]},{"DOI":"10.13039\/501100007482","name":"Universidad Nacional de Tucum\u00e1n","doi-asserted-by":"crossref","award":["PIUNT D542\/1, D644\/1, and D759"],"award-info":[{"award-number":["PIUNT D542\/1, D644\/1, and D759"]}],"id":[{"id":"10.13039\/501100007482","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007482","name":"Universidad Nacional de Tucum\u00e1n","doi-asserted-by":"crossref","award":["PIUNT D542\/1, D644\/1, and D759"],"award-info":[{"award-number":["PIUNT D542\/1, D644\/1, and D759"]}],"id":[{"id":"10.13039\/501100007482","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007482","name":"Universidad Nacional de Tucum\u00e1n","doi-asserted-by":"crossref","award":["PIUNT D542\/1, D644\/1, and D759"],"award-info":[{"award-number":["PIUNT D542\/1, D644\/1, and D759"]}],"id":[{"id":"10.13039\/501100007482","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007482","name":"Universidad Nacional de Tucum\u00e1n","doi-asserted-by":"crossref","award":["PIUNT D542\/1, D644\/1, and D759"],"award-info":[{"award-number":["PIUNT D542\/1, D644\/1, and D759"]}],"id":[{"id":"10.13039\/501100007482","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"crossref","award":["GAO 2018, DOXY- PARK"],"award-info":[{"award-number":["GAO 2018, DOXY- PARK"]}],"id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"crossref","award":["GAO 2018, DOXY- PARK"],"award-info":[{"award-number":["GAO 2018, DOXY- PARK"]}],"id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"crossref","award":["GAO 2018, DOXY- PARK"],"award-info":[{"award-number":["GAO 2018, DOXY- PARK"]}],"id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"crossref","award":["GAO 2018, DOXY- PARK"],"award-info":[{"award-number":["GAO 2018, DOXY- PARK"]}],"id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"crossref","award":["GAO 2018, DOXY- PARK"],"award-info":[{"award-number":["GAO 2018, DOXY- PARK"]}],"id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"crossref","award":["GAO 2018, DOXY- PARK"],"award-info":[{"award-number":["GAO 2018, DOXY- PARK"]}],"id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15991-w","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:12:28Z","timestamp":1761750748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["DDOX expands the repertoire of tetracyclines for Parkinson\u2019s disease by preventing the cellular uptake and intracellular impact of \u03b1-synuclein preformed fibrils"],"prefix":"10.1038","volume":"15","author":[{"given":"Mar\u00eda del Milagro","family":"Teran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Hern\u00e1n","family":"Tomas-Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda Silvana","family":"Soliz-Santander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Guay\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Budeguer Isa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Luna Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar Luis","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Sosa-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaila","family":"Ciss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Besnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Benjam\u00edn","family":"Socias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Vera Pingitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Ferri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Raisman-Vozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Figad\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana Nieves","family":"Cheh\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ploper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"15991_CR1","doi-asserted-by":"publisher","unstructured":"Global regional, and National burden of parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 17, 939\u2013953. https:\/\/doi.org\/10.1016\/s1474-4422(18)30295-3 (2018).","DOI":"10.1016\/s1474-4422(18)30295-3"},{"key":"15991_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. & Bloem, B. R. The Parkinson Pandemic-A call to action. JAMA Neurol. 75, 9\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299 (2018).","journal-title":"JAMA Neurol."},{"key":"15991_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Current and projected future economic burden of parkinson\u2019s disease in the U.S. NPJ Parkinson\u2019s Disease. 6, 15. https:\/\/doi.org\/10.1038\/s41531-020-0117-1 (2020).","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"15991_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/jpd-239901","volume":"13","author":"K McFarthing","year":"2023","unstructured":"McFarthing, K. et al. Parkinson\u2019s disease drug therapies in the clinical trial pipeline: 2023 update. J. Parkinson\u2019s Disease. 13, 427\u2013439. https:\/\/doi.org\/10.3233\/jpd-239901 (2023).","journal-title":"J. Parkinson\u2019s Disease"},{"key":"15991_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S. & Li-Hua, P. Signaling pathways in parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal. Transduct. Target. Therapy. 8, 73. https:\/\/doi.org\/10.1038\/s41392-023-01353-3 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"15991_CR6","doi-asserted-by":"publisher","unstructured":"Dugger, B. N. & Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9, 856.  https:\/\/doi.org\/10.1101\/cshperspect.a028035 (2017).","DOI":"10.1101\/cshperspect.a028035"},{"key":"15991_CR7","doi-asserted-by":"publisher","unstructured":"Wilson, D. M. 3rd et al. Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714.   https:\/\/doi.org\/10.1016\/j.cell.2022.12.032 (2023).","DOI":"10.1016\/j.cell.2022.12.032"},{"key":"15991_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/jnc.14808","volume":"150","author":"P Alam","year":"2019","unstructured":"Alam, P., Bousset, L., Melki, R. & Otzen, D. E. \u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. J. Neurochem. 150, 522\u2013534. https:\/\/doi.org\/10.1111\/jnc.14808 (2019).","journal-title":"J. Neurochem."},{"key":"15991_CR9","doi-asserted-by":"publisher","unstructured":"Burr\u00e9, J., Sharma, M. & S\u00fcdhof, T. C. Cell biology and pathophysiology of \u03b1-Synuclein. Cold Spring Harbor Perspect. Med. 8, 856.  https:\/\/doi.org\/10.1101\/cshperspect.a024091 (2018).","DOI":"10.1101\/cshperspect.a024091"},{"key":"15991_CR10","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/jpd-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Jakes, R. & Spillantini, M. G. The synucleinopathies: twenty years on. J. Parkinson\u2019s Disease. 7, S51\u2013s69. https:\/\/doi.org\/10.3233\/jpd-179005 (2017).","journal-title":"J. Parkinson\u2019s Disease"},{"key":"15991_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Tredici, D., Braak, H. & K. & 100 years of lewy pathology. Nat. Reviews Neurol. 9, 13\u201324. https:\/\/doi.org\/10.1038\/nrneurol.2012.242 (2013).","journal-title":"Nat. Reviews Neurol."},{"key":"15991_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in lewy bodies. Nature 388, 839\u2013840. https:\/\/doi.org\/10.1038\/42166 (1997).","journal-title":"Nature"},{"key":"15991_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang, W. et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in parkinson\u2019s disease. FASEB J. 19, 533\u2013542. https:\/\/doi.org\/10.1096\/fj.04-2751com (2005).","journal-title":"FASEB J."},{"key":"15991_CR14","doi-asserted-by":"publisher","unstructured":"Arawaka, S., Sato, H., Sasaki, A., Koyama, S. & Kato, T. Mechanisms underlying extensive Ser129-phosphorylation in \u03b1-synuclein aggregates. Acta Neuropathol. Commun. 5, 523.  https:\/\/doi.org\/10.1186\/s40478-017-0452-6 (2017).","DOI":"10.1186\/s40478-017-0452-6"},{"key":"15991_CR15","doi-asserted-by":"publisher","unstructured":"Finkbeiner, S. The autophagy lysosomal pathway and neurodegeneration. Cold Spring Harb. Perspect. Biol. 12, 523.  https:\/\/doi.org\/10.1101\/cshperspect.a033993 (2020).","DOI":"10.1101\/cshperspect.a033993"},{"key":"15991_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.11.015","volume":"73","author":"K Senkevich","year":"2020","unstructured":"Senkevich, K. & Gan-Or, Z. Autophagy lysosomal pathway dysfunction in parkinson\u2019s disease; evidence from human genetics. Parkinsonism Relat. Disord. 73, 60\u201371. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.11.015 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"15991_CR17","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new parkinson\u2019s disease risk loci. Nat. Genet. 49, 1511\u20131516. https:\/\/doi.org\/10.1038\/ng.3955 (2017).","journal-title":"Nat. Genet."},{"key":"15991_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awy147","volume":"141","author":"AD Klein","year":"2018","unstructured":"Klein, A. D. & Mazzulli, J. R. Is parkinson\u2019s disease a lysosomal disorder? Brain: J. Neurol. 141, 2255\u20132262. https:\/\/doi.org\/10.1093\/brain\/awy147 (2018).","journal-title":"Brain: J. Neurol."},{"key":"15991_CR19","doi-asserted-by":"publisher","first-page":"681369","DOI":"10.3389\/fneur.2021.681369","volume":"12","author":"T Abe","year":"2021","unstructured":"Abe, T. & Kuwahara, T. Targeting of lysosomal pathway genes for parkinson\u2019s disease modification: insights from cellular and animal models. Front. Neurol. 12, 681369. https:\/\/doi.org\/10.3389\/fneur.2021.681369 (2021).","journal-title":"Front. Neurol."},{"key":"15991_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.conb.2022.01.003","volume":"72","author":"NP Marotta","year":"2022","unstructured":"Marotta, N. P. & Lee, V. M. Modeling the cellular fate of alpha-synuclein aggregates: a pathway to pathology. Curr. Opin. Neurobiol. 72, 171\u2013177. https:\/\/doi.org\/10.1016\/j.conb.2022.01.003 (2022).","journal-title":"Curr. Opin. Neurobiol."},{"key":"15991_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-021-00203-9","volume":"7","author":"LMA Oliveira","year":"2021","unstructured":"Oliveira, L. M. A. et al. Alpha-synuclein research: defining strategic moves in the battle against parkinson\u2019s disease. NPJ Parkinson\u2019s Disease. 7, 65. https:\/\/doi.org\/10.1038\/s41531-021-00203-9 (2021).","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"15991_CR22","doi-asserted-by":"publisher","unstructured":"Bortolanza, M. et al. Tetracycline repurposing in neurodegeneration: focus on Parkinson\u2019s disease. J. Neural Transm. (Vienna, Austria 125, 1403\u20131415. https:\/\/doi.org\/10.1007\/s00702-018-1913-1 (2018).","DOI":"10.1007\/s00702-018-1913-1"},{"key":"15991_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00702-021-02457-2","volume":"129","author":"I Markulin","year":"2022","unstructured":"Markulin, I., Matasin, M., Turk, V. E. & Salkovi\u0107-Petrisic, M. Challenges of repurposing tetracyclines for the treatment of alzheimer\u2019s and parkinson\u2019s disease. J. Neural Transmission (Vienna Austria: 1996). 129, 773\u2013804. https:\/\/doi.org\/10.1007\/s00702-021-02457-2 (2022).","journal-title":"J. Neural Transmission (Vienna Austria: 1996)"},{"key":"15991_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1128\/aac.40.5.1104","volume":"40","author":"M Karlsson","year":"1996","unstructured":"Karlsson, M., Hammers, S., Nilsson-Ehle, I., Malmborg, A. S. & Wretlind, B. Concentrations of Doxycycline and penicillin G in Sera and cerebrospinal fluid of patients treated for neuroborreliosis. Antimicrob. Agents Chemother. 40, 1104\u20131107. https:\/\/doi.org\/10.1128\/aac.40.5.1104 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"15991_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1124\/jpet.118.252064","volume":"368","author":"J Lucchetti","year":"2019","unstructured":"Lucchetti, J. et al. Plasma and brain concentrations of Doxycycline after single and repeated doses in Wild-Type and APP23 mice. J. Pharmacol. Exp. Ther. 368, 32\u201340. https:\/\/doi.org\/10.1124\/jpet.118.252064 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"15991_CR26","doi-asserted-by":"publisher","unstructured":"Dominguez-Meijide, A. et al. Doxycycline inhibits \u03b1-synuclein-associated pathologies in vitro and in vivo. Neurobiol. Dis. 151, 856. https:\/\/doi.org\/10.1016\/j.nbd.2021.105256 (2021).","DOI":"10.1016\/j.nbd.2021.105256"},{"key":"15991_CR27","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du, Y. et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of parkinson\u2019s disease. Proc. Natl. Acad. Sci. U.S.A. 98, 14669\u201314674. https:\/\/doi.org\/10.1073\/pnas.251341998 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"15991_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","volume":"73","author":"A Egeberg","year":"2016","unstructured":"Egeberg, A., Hansen, P. R., Gislason, G. H. & Thyssen, J. P. Exploring the association between rosacea and Parkinson disease: a Danish nationwide cohort study. JAMA Neurol. 73, 529\u2013534. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0022 (2016).","journal-title":"JAMA Neurol."},{"key":"15991_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1871526510909010023","volume":"9","author":"G Forloni","year":"2009","unstructured":"Forloni, G., Salmona, M., Marcon, G. & Tagliavini, F. Tetracyclines and prion infectivity. Infect. Disord. Drug Targ. 9, 23\u201330. https:\/\/doi.org\/10.2174\/1871526510909010023 (2009).","journal-title":"Infect. Disord. Drug Targ."},{"key":"15991_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics1010001","volume":"1","author":"D Fuoco","year":"2012","unstructured":"Fuoco, D. Classification framework and chemical biology of Tetracycline-Structure-Based drugs. Antibiot. (Basel Switzerland). 1, 1\u201313. https:\/\/doi.org\/10.3390\/antibiotics1010001 (2012).","journal-title":"Antibiot. (Basel Switzerland)"},{"key":"15991_CR31","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1074\/jbc.M110.178376","volume":"286","author":"S Giorgetti","year":"2011","unstructured":"Giorgetti, S. et al. Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J. Biol. Chem. 286, 2121\u20132131. https:\/\/doi.org\/10.1074\/jbc.M110.178376 (2011).","journal-title":"J. Biol. Chem."},{"key":"15991_CR32","doi-asserted-by":"publisher","first-page":"20258","DOI":"10.1038\/s41598-020-76927-0","volume":"10","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2020","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga, F. et al. CMT-3 targets different \u03b1-synuclein aggregates mitigating their toxic and inflammogenic effects. Sci. Rep. 10, 20258. https:\/\/doi.org\/10.1038\/s41598-020-76927-0 (2020).","journal-title":"Sci. Rep."},{"key":"15991_CR33","doi-asserted-by":"publisher","first-page":"41755","DOI":"10.1038\/srep41755","volume":"7","author":"F Gonz\u00e1lez-Liz\u00e1rraga","year":"2017","unstructured":"Gonz\u00e1lez-Liz\u00e1rraga, F. et al. Repurposing Doxycycline for synucleinopathies: remodelling of \u03b1-synuclein oligomers towards non-toxic parallel beta-sheet structured species. Sci. Rep. 7, 41755. https:\/\/doi.org\/10.1038\/srep41755 (2017).","journal-title":"Sci. Rep."},{"key":"15991_CR34","doi-asserted-by":"publisher","first-page":"105229","DOI":"10.1016\/j.parkreldis.2022.105229","volume":"106","author":"P La Vitola","year":"2023","unstructured":"La Vitola, P. et al. Repositioning Doxycycline for treating synucleinopathies: evidence from a pre-clinical mouse model. Parkinsonism Relat. Disord. 106, 105229. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.105229 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"15991_CR35","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/187152709788680689","volume":"8","author":"D Orsucci","year":"2009","unstructured":"Orsucci, D., Calsolaro, V., Mancuso, M. & Siciliano, G. Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol. Disord. Drug Target. 8, 222\u2013231. https:\/\/doi.org\/10.2174\/187152709788680689 (2009).","journal-title":"CNS Neurol. Disord. Drug Target"},{"key":"15991_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2017.12.002","volume":"162","author":"SB Socias","year":"2018","unstructured":"Socias, S. B. et al. Exploiting the therapeutic potential of ready-to-use drugs: repurposing antibiotics against amyloid aggregation in neurodegenerative diseases. Prog. Neurobiol. 162, 17\u201336. https:\/\/doi.org\/10.1016\/j.pneurobio.2017.12.002 (2018).","journal-title":"Prog. Neurobiol."},{"key":"15991_CR37","doi-asserted-by":"publisher","unstructured":"Tomas-Grau, R. et al. Neuroprotective effects of a novel Demeclocycline derivative lacking antibiotic activity: from a hit to a promising lead compound. Cells 11, 523. https:\/\/doi.org\/10.3390\/cells11172759 (2022).","DOI":"10.3390\/cells11172759"},{"key":"15991_CR38","doi-asserted-by":"publisher","unstructured":"Tourville, A. et al. Rescue of dopamine neurons from Iron-Dependent ferroptosis by Doxycycline and Demeclocycline and their Non-Antibiotic derivatives. Anyioxidants (Basel). 12, 523.  https:\/\/doi.org\/10.3390\/antiox12030575 (2023).","DOI":"10.3390\/antiox12030575"},{"key":"15991_CR39","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.4c00169","author":"D Ploper","year":"2024","unstructured":"Ploper, D. et al. Design, synthesis, and evaluation of a novel conjugate molecule with dopaminergic and neuroprotective activities for parkinson\u2019s disease. ACS Chem. Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.4c00169 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"15991_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41531-025-00966-5","volume":"11","author":"P Stalder","year":"2025","unstructured":"Stalder, P. et al. An approach to characterize mechanisms of action of anti-amyloidogenic compounds in vitro and in situ. NPJ Parkinson\u2019s Dis. 11, 122. https:\/\/doi.org\/10.1038\/s41531-025-00966-5 (2025).","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"15991_CR41","doi-asserted-by":"publisher","unstructured":"Santos-Lobato, B. L. et al. Doxycycline to treat levodopa-induced dyskinesias in Parkinson\u2019s disease: a preliminary study. Arquivos de neuro-psiquiatria 81, 460\u2013468. https:\/\/doi.org\/10.1055\/s-0043-1768668   (2023).","DOI":"10.1055\/s-0043-1768668"},{"key":"15991_CR42","doi-asserted-by":"publisher","unstructured":"Rose, C. et al. C9-functionalized doxycycline analogs as drug candidates to prevent pathological \u03b1-synuclein aggregation and neuroinflammation in Parkinson\u2019s disease degeneration. ChemMedChem  2024, e202300597. https:\/\/doi.org\/10.1002\/cmdc.202300597 (2024).","DOI":"10.1002\/cmdc.202300597"},{"key":"15991_CR43","doi-asserted-by":"publisher","unstructured":"Nascimento, G. C. et al. Anti-nociceptive effects of non-antibiotic derivatives of Demeclocycline and Doxycycline against formalin-induced pain stimulation. Eur. J. Pharmacol. 984, 523. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177054 (2024).","DOI":"10.1016\/j.ejphar.2024.177054"},{"key":"15991_CR44","doi-asserted-by":"publisher","unstructured":"Morgan, G. J. Barriers to small molecule drug discovery for systemic amyloidosis. Mol. (Basel Switzerland) 26, 236. https:\/\/doi.org\/10.3390\/molecules26123571 (2021).","DOI":"10.3390\/molecules26123571"},{"key":"15991_CR45","doi-asserted-by":"publisher","first-page":"17497","DOI":"10.1074\/jbc.RA120.013428","volume":"295","author":"SJ Guiney","year":"2020","unstructured":"Guiney, S. J. et al. Fibrillar \u03b1-synuclein toxicity depends on functional lysosomes. J. Biol. Chem. 295, 17497\u201317513. https:\/\/doi.org\/10.1074\/jbc.RA120.013428 (2020).","journal-title":"J. Biol. Chem."},{"key":"15991_CR46","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U.S.A. 106, 20051\u201320056. https:\/\/doi.org\/10.1073\/pnas.0908005106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"15991_CR47","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to lewy body and lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146. https:\/\/doi.org\/10.1038\/nprot.2014.143 (2014).","journal-title":"Nat. Protoc."},{"key":"15991_CR48","doi-asserted-by":"publisher","unstructured":"Grossman, T. H. Tetracycline antibiotics and resistance. Cold Spring Harbor Perspect. Med. 6, a025387.  https:\/\/doi.org\/10.1101\/cshperspect.a025387   (2016).","DOI":"10.1101\/cshperspect.a025387"},{"key":"15991_CR49","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s12640-019-00015-z","volume":"35","author":"FV Santa-Cec\u00edlia","year":"2019","unstructured":"Santa-Cec\u00edlia, F. V., Leite, C. A. & Del-Bel, E. Raisman-Vozari, R. The neuroprotective effect of Doxycycline on neurodegenerative diseases. Neurotox. Res. 35, 981\u2013986. https:\/\/doi.org\/10.1007\/s12640-019-00015-z (2019).","journal-title":"Neurotox. Res."},{"key":"15991_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12640-015-9592-2","volume":"29","author":"FV Santa-Cec\u00edlia","year":"2016","unstructured":"Santa-Cec\u00edlia, F. V. et al. Doxycycline suppresses microglial activation by inhibiting the p38 MAPK and NF-kB signaling pathways. Neurotox. Res. 29, 447\u2013459. https:\/\/doi.org\/10.1007\/s12640-015-9592-2 (2016).","journal-title":"Neurotox. Res."},{"key":"15991_CR51","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1021\/acschemneuro.2c00478","volume":"13","author":"C Feng","year":"2022","unstructured":"Feng, C. et al. Observation of \u03b1-Synuclein preformed fibrils interacting with SH-SY5Y neuroblastoma cell membranes using scanning ion conductance microscopy. ACS Chem. Neurosci. 13, 3547\u20133553. https:\/\/doi.org\/10.1021\/acschemneuro.2c00478 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"15991_CR52","doi-asserted-by":"publisher","unstructured":"Galkin, M., Priss, A., Kyriukha, Y. & Shvadchak, V. Navigating \u03b1-Synuclein aggregation inhibition: methods, mechanisms, and molecular targets. Chem. Record (New York N Y) 24,  e202300282. https:\/\/doi.org\/10.1002\/tcr.202300282 (2024).","DOI":"10.1002\/tcr.202300282"},{"key":"15991_CR53","doi-asserted-by":"publisher","first-page":"e2217835120","DOI":"10.1073\/pnas.2217835120","volume":"120","author":"KA Murray","year":"2023","unstructured":"Murray, K. A. et al. Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils. Proc. Natl. Acad. Sci. USA. 120, e2217835120. https:\/\/doi.org\/10.1073\/pnas.2217835120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"15991_CR54","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols, J. et al. Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc. Natl. Acad. Sci. USA. 115, 10481\u201310486. https:\/\/doi.org\/10.1073\/pnas.1804198115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"15991_CR55","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1021\/acschemneuro.1c00379","volume":"12","author":"B Saffari","year":"2021","unstructured":"Saffari, B. & Amininasab, M. Crocin inhibits the fibrillation of human \u03b1-synuclein and disassembles mature fibrils: experimental findings and mechanistic insights from molecular dynamics simulation. ACS Chem. Neurosci. 12, 4037\u20134057. https:\/\/doi.org\/10.1021\/acschemneuro.1c00379 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"15991_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033 (2011).","journal-title":"Neuron"},{"key":"15991_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164. https:\/\/doi.org\/10.1038\/ncb748 (2002).","journal-title":"Nat. Cell Biol."},{"key":"15991_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/jpd-160779","volume":"6","author":"A Oueslati","year":"2016","unstructured":"Oueslati, A. Implication of Alpha-Synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?? J. Parkinson\u2019s Disease. 6, 39\u201351. https:\/\/doi.org\/10.3233\/jpd-160779 (2016).","journal-title":"J. Parkinson\u2019s Disease"},{"key":"15991_CR59","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1074\/jbc.M115.705095","volume":"291","author":"F Samuel","year":"2016","unstructured":"Samuel, F. et al. Effects of Serine 129 phosphorylation on \u03b1-Synuclein aggregation, membrane association, and internalization. J. Biol. Chem. 291, 4374\u20134385. https:\/\/doi.org\/10.1074\/jbc.M115.705095 (2016).","journal-title":"J. Biol. Chem."},{"key":"15991_CR60","doi-asserted-by":"publisher","unstructured":"Bussi, C. et al. Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells. J. Cell Sci. 131, 693. https:\/\/doi.org\/10.1242\/jcs.226241 (2018).","DOI":"10.1242\/jcs.226241"},{"key":"15991_CR61","doi-asserted-by":"publisher","first-page":"e3001287","DOI":"10.1371\/journal.pbio.3001287","volume":"19","author":"A Dilsizoglu Senol","year":"2021","unstructured":"Dilsizoglu Senol, A. et al. \u03b1-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. PLoS Biol. 19, e3001287. https:\/\/doi.org\/10.1371\/journal.pbio.3001287 (2021).","journal-title":"PLoS Biol."},{"key":"15991_CR62","doi-asserted-by":"publisher","unstructured":"Patterson, J. R. et al. Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. NPJ Parkinson\u2019s disease. 10, 856. https:\/\/doi.org\/10.1038\/s41531-023-00620-y (2024).","DOI":"10.1038\/s41531-023-00620-y"},{"key":"15991_CR63","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1110\/ps.0240003","volume":"12","author":"MS Celej","year":"2003","unstructured":"Celej, M. S., Montich, G. G. & Fidelio, G. D. Protein stability induced by ligand binding correlates with changes in protein flexibility. Protein Science: Publication Protein Soc. 12, 1496\u20131506. https:\/\/doi.org\/10.1110\/ps.0240003 (2003).","journal-title":"Protein Science: Publication Protein Soc."},{"key":"15991_CR64","doi-asserted-by":"publisher","unstructured":"Domingues, R. et al. Extracellular alpha-synuclein: sensors, receptors, and responses. Neurobiol. Dis. 168, 856.  https:\/\/doi.org\/10.1016\/j.nbd.2022.105696 (2022).","DOI":"10.1016\/j.nbd.2022.105696"},{"key":"15991_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat. Struct. Mol. Biol. 23, 409\u2013415. https:\/\/doi.org\/10.1038\/nsmb.3194 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"15991_CR66","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1021\/bi900539p","volume":"48","author":"EA Waxman","year":"2009","unstructured":"Waxman, E. A., Mazzulli, J. R. & Giasson, B. I. Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization. Biochemistry 48, 9427\u20139436. https:\/\/doi.org\/10.1021\/bi900539p (2009).","journal-title":"Biochemistry"},{"key":"15991_CR67","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1091\/mbc.E14-02-0708","volume":"25","author":"DJ Busch","year":"2014","unstructured":"Busch, D. J. et al. Acute increase of \u03b1-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation. Mol. Biol. Cell. 25, 3926\u20133941. https:\/\/doi.org\/10.1091\/mbc.E14-02-0708 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"15991_CR68","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443\u20139449. https:\/\/doi.org\/10.1074\/jbc.273.16.9443 (1998).","journal-title":"J. Biol. Chem."},{"key":"15991_CR69","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1073\/pnas.0807826105","volume":"105","author":"CC Jao","year":"2008","unstructured":"Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S. & Langen, R. Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc. Natl. Acad. Sci. U.S.A. 105, 19666\u201319671. https:\/\/doi.org\/10.1073\/pnas.0807826105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"15991_CR70","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1021\/ja312415q","volume":"135","author":"AS Maltsev","year":"2013","unstructured":"Maltsev, A. S., Chen, J., Levine, R. L. & Bax, A. Site-specific interaction between \u03b1-synuclein and membranes probed by NMR-observed methionine oxidation rates. J. Am. Chem. Soc. 135, 2943\u20132946. https:\/\/doi.org\/10.1021\/ja312415q (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"15991_CR71","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3389\/fncel.2019.00540","volume":"13","author":"EN Anderson","year":"2019","unstructured":"Anderson, E. N., Hirpa, D., Zheng, K. H., Banerjee, R. & Gunawardena, S. The Non-amyloidal component region of \u03b1-Synuclein is important for \u03b1-Synuclein transport within axons. Front. Cell. Neurosci. 13, 540. https:\/\/doi.org\/10.3389\/fncel.2019.00540 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"15991_CR72","doi-asserted-by":"publisher","unstructured":"Tofaris, G. K., Goedert, M. & Spillantini, M. G. The transcellular propagation and intracellular trafficking of \u03b1-Synuclein. Cold Spring Harbor Perspect. Med. 7, 785. https:\/\/doi.org\/10.1101\/cshperspect.a024380 (2017).","DOI":"10.1101\/cshperspect.a024380"},{"key":"15991_CR73","doi-asserted-by":"publisher","unstructured":"Mao, X. et al. Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Sci. (New York N Y). 353, 526. https:\/\/doi.org\/10.1126\/science.aah3374 (2016).","DOI":"10.1126\/science.aah3374"},{"key":"15991_CR74","doi-asserted-by":"publisher","first-page":"852003","DOI":"10.3389\/fneur.2022.852003","volume":"13","author":"S Menon","year":"2022","unstructured":"Menon, S. et al. Alpha-Synuclein targeting therapeutics for parkinson\u2019s disease and related synucleinopathies. Front. Neurol. 13, 852003. https:\/\/doi.org\/10.3389\/fneur.2022.852003 (2022).","journal-title":"Front. Neurol."},{"key":"15991_CR75","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","volume":"7","author":"HT Tran","year":"2014","unstructured":"Tran, H. T. et al. \u0391-synuclein immunotherapy blocks uptake and templated propagation of misfolded \u03b1-synuclein and neurodegeneration. Cell. Rep. 7, 2054\u20132065. https:\/\/doi.org\/10.1016\/j.celrep.2014.05.033 (2014).","journal-title":"Cell. Rep."},{"key":"15991_CR76","doi-asserted-by":"publisher","first-page":"14342","DOI":"10.1038\/s41598-023-41382-0","volume":"13","author":"H Geerts","year":"2023","unstructured":"Geerts, H., Bergeler, S., Walker, M., van der Graaf, P. H. & Courade, J. P. Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems Pharmacology model. Sci. Rep. 13, 14342. https:\/\/doi.org\/10.1038\/s41598-023-41382-0 (2023).","journal-title":"Sci. Rep."},{"key":"15991_CR77","doi-asserted-by":"publisher","first-page":"635760","DOI":"10.3389\/fnagi.2021.635760","volume":"13","author":"L Medina","year":"2021","unstructured":"Medina, L. et al. Doxycycline interferes with Tau aggregation and reduces its neuronal toxicity. Front. Aging Neurosci. 13, 635760. https:\/\/doi.org\/10.3389\/fnagi.2021.635760 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"15991_CR78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jmb.2005.08.046","volume":"353","author":"J Kaylor","year":"2005","unstructured":"Kaylor, J. et al. Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W\/Y133F\/Y136F alpha-synuclein. J. Mol. Biol. 353, 357\u2013372. https:\/\/doi.org\/10.1016\/j.jmb.2005.08.046 (2005).","journal-title":"J. Mol. Biol."},{"key":"15991_CR79","doi-asserted-by":"publisher","unstructured":"Fielding, L. et al. Current safety recommendations for handling mouse and human \u03b1synuclein pre-formed fibrils. Neurobiol. Dis. 206, 236. https:\/\/doi.org\/10.1016\/j.nbd.2025.106820 (2025).","DOI":"10.1016\/j.nbd.2025.106820"},{"key":"15991_CR80","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0076-6879(99)09020-5","volume":"309","author":"H LeVine","year":"1999","unstructured":"LeVine, H. 3 Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274\u2013284. https:\/\/doi.org\/10.1016\/s0076-6879(99)09020-5 (1999).","journal-title":"Methods Enzymol."},{"key":"15991_CR81","doi-asserted-by":"publisher","first-page":"E420","DOI":"10.1073\/pnas.1424576112","volume":"112","author":"D Ploper","year":"2015","unstructured":"Ploper, D. et al. MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 112, E420\u2013429. https:\/\/doi.org\/10.1073\/pnas.1424576112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"15991_CR82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0887-2333(94)00193-x","volume":"9","author":"MR Cookson","year":"1995","unstructured":"Cookson, M. R., Mead, C., Austwick, S. M. & Pentreath, V. W. Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell cultures. Toxicol. Vitro: Int. J. Published Association BIBRA. 9, 39\u201348. https:\/\/doi.org\/10.1016\/0887-2333(94)00193-x (1995).","journal-title":"Toxicol. Vitro: Int. J. Published Association BIBRA"},{"key":"15991_CR83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4 (1983).","journal-title":"J. Immunol. Methods"},{"key":"15991_CR84","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fncel.2013.00176","volume":"7","author":"L Fang","year":"2013","unstructured":"Fang, L., Li, J., Flammer, J. & Neutzner, A. MARCH5 inactivation supports mitochondrial function during neurodegenerative stress. Front. Cell. Neurosci. 7, 176. https:\/\/doi.org\/10.3389\/fncel.2013.00176 (2013).","journal-title":"Front. Cell. Neurosci."},{"key":"15991_CR85","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"key":"15991_CR86","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Science: Publication Protein Soc. 30, 70\u201382. https:\/\/doi.org\/10.1002\/pro.3943 (2021).","journal-title":"Protein Science: Publication Protein Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15991-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15991-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15991-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:12:29Z","timestamp":1761750749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15991-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15991"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15991-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.F., P.P.M., R.R-V., and B.F. are listed as inventors on patent applications filed for the use of non-antibiotic tetracycline derivatives for the treatment of PD and related disorders. M.M.T, R.H.T-G, E.S.S-S, M.L.G., V.B.I., A.L.M., C.L.A., B.S-P., H.C., I.C., P.B., S.B.S., E.V.P., R.N.C. and D.P. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37769"}}